Silventum Overview

  • Founded
  • 2017

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $200K

  • Investors
  • 3

Silventum General Information


Developer of dental filling materials intended to resist bacterial infection. The company's materials assist in providing resistance to bacterial infection with mechanical, structural, and aesthetic qualities, enabling dentists to help patients prevent dental decay or cavities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Medical Supplies
Primary Office
  • 87 Saint David Street
  • North Dunedin
  • Dunedin, 9016
  • New Zealand

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Silventum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 13-Feb-2018 $200K Completed Startup
1. Seed Round 22-Dec-2017 Completed Startup
To view Silventum’s complete valuation and funding history, request access »

Silventum Executive Team (3)

Name Title Board Seat Contact Info
Stephen Silvey Co-Founder & Board Member
You’re viewing 1 of 3 executive team members. Get the full list »

Silventum Board Members (2)

Name Representing Role Since
Peter Hodgson Self Board Member 000 0000
Stephen Silvey Self Co-Founder & Board Member 000 0000
To view Silventum’s complete board members history, request access »

Silventum Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Royal Society of New Zealand Government 000 0000 000000 0
Powerhouse Ventures (Christchurch) Venture Capital Minority 000 0000 000000 0
University of Otago Accelerator/Incubator Minority 000 0000 000000 0
To view Silventum’s complete investors history, request access »